抗流感病毒小RNAs研究进展

doi:10.3724/SP.J.1005.2012.00526

遗传 ›› 2012, Vol. 34 ›› Issue (5): 526-532.doi: 10.3724/SP.J.1005.2012.00526

抗流感病毒小RNAs研究进展

郑维豪, 林志强, 卓敏, 杜红丽, 王小宁

华南理工大学生物科学与工程学院, 广州 510006

收稿日期:2011-09-01 修回日期:2011-11-16 出版日期:2012-05-20 发布日期:2012-05-25
通讯作者: 杜红丽 E-mail:hldu@scut.edu.cn
基金资助:
十二五“重大新药创制”专项项目(编号: 2011ZX09307-303-03), 广东省科技计划项目（编号: 2010B060200007）和国家大学生创新性实验计划项目(编号: 091056153)资助

Research progress on influenza antiviral small RNAs

ZHENG Wei-Hao, LIN Zhi-Qiang, ZHUO Min, DU Hong-Li, WANG Xiao-Ning

School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510006, China

Received:2011-09-01 Revised:2011-11-16 Online:2012-05-20 Published:2012-05-25
Contact: Hongli Du E-mail:hldu@scut.edu.cn

摘要/Abstract

摘要： 流行性感冒是一类由流感病毒引起的呼吸道传染病, 通过季节性流行或全球性爆发严重威胁着人类健康。目前防治流感的主要方法是疫苗和药物, 但存在神经毒性、肠胃副作用、易耐药等诸多限制因素。新的技术特别是小RNAs介导的RNA干扰(RNAi)技术, 因其具有高效、特异、快速等特点, 已成为抗病毒治疗的候选方法之一。随着近年来流感病毒的流行, 应用小RNAs抗流感病毒的报导越来越多, 其中靶向PA、NP和M2的PA-2087, NP-1496和M-950是目前报道的抑制流感病毒效果最好的siRNA。靶向不同流感病毒基因保守区域的siRNA具有更广泛的病毒毒株抑制效果, 靶向不同基因的siRNAs联合使用可取得更好的病毒抑制效果。文章就目前siRNAs和miRNAs在抗流感病毒方面的研究进展及RNAi治疗的前景和问题进行了综述。

关键词: 流感病毒, 小RNAs, siRNAs, miRNAs, RNAi

Abstract: Worldwide influenza caused by influenza virus is a respiratory disease which threats the public health by seasonal epidemics or global influenza outbreak. Vaccines and drugs are current therapies, but there are many restricted factors such as neurotoxicity, side effects of gastrointestinal, and drug resistance. New technologies, particularly RNAi mediated by small RNAs, has become a potential and robust method in influenza antiviral research for its high efficiency, specific, and speedy. Following the spread and epidemic of the influenza virus, application of small RNAs into influenza antiviral research has been reported increasingly. The small RNAs, PA-2087, NP-1496, and M-950, which targets PA, NP, and M2 genes, respectively, are the most effective anti-influenza siRNAs up to now. siRNA of targeting conservative region of different influenza viral genes has broader effect on virus inhibition. The combination of siRNAs of targeting different genes can achieve better virus inhibition. In this review, we mainly described the progress of siRNAs and miRNAs for anti-influenza virus, and the prospects and hurdles of influenza RNAi therapy as well.

Key words: influenza virus, small RNAs, siRNAs, miRNAs, RNAi

郑维豪，林志强，卓敏，杜红丽，王小宁. 抗流感病毒小RNAs研究进展[J]. 遗传, 2012, 34(5): 526-532.

ZHENG Wei-Hao, LIN Zhi-Qiang, ZHUO Min, DU Hong-Li, WANG Xiao-Ning. Research progress on influenza antiviral small RNAs[J]. HEREDITAS, 2012, 34(5): 526-532.

参考文献

[1] Tsai KN, Chen GW. Influenza genome diversity and evolution. Microbes Infect, 2011, 13(5): 479-488.
[2] Ginsberg J, Mohebbi MH, Patel RS, Brammer L, Smolinski MS, Brilliant L. Detecting influenza epidemics using search engine query data. Nature, 2008, 457(7232): 1012-1014.
[3] Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature, 2009, 459(7249): 931-939.
[4] Nelson MI, Holmes EC. The evolution of epidemic influenza. Nat Rev Genet, 2007, 8(3): 196-205.
[5] Smith GJD, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JSM, Guan Y, Rambaut A. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature, 2009, 459(7250): 1122-1125.
[6] Zhang J, Xu WF. Recent advances in anti-influenza agents with neuraminidase as target. Mini Rev Med Chem, 2006, 6(4): 429-448.
[7] De Clercq E. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov, 2006, 5(12): 1015-1025.
[8] Lagoja IM, De Clercq E. Anti-influenza virus agents: Synthesis and mode of action. Med Res Rev, 2008, 28(1): 1-38.
[9] Sugrue RJ, Tan BH, Yeo DS, Sutejo R. Antiviral drugs for the control of pandemic influenza virus. Ann Acad Med, 2008, 37(6): 518-524.
[10] Moss RB, Davey RT, Steigbigel RT, Fang F. Targeting pandemic influenza: a primer on influenza antivirals and drug resistance. J Antimicrob Chemoth, 2010, 65(6): 1086-1093.
[11] Fuyuno I. Tamiflu side effects come under scrutiny. Nature, 2007, 446(7134): 358-359.
[12] Bridges CB, Harper SA, Fukuda K Uyeki TM, Cox NJ, Singleton JA, Advisory Committee on Immunization Practices. Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2008, 57(RR-8): 1-34.
[13] Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Bio, 2009, 10(2): 126-139.
[14] Czech B, Hannon GJ. Small RNA sorting: matchmaking for Argonautes. Nat Rev Genet, 2010, 12(1): 19-31.
[15] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75(5): 843-854.
[16] Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell, 1993, 75 (5): 855-862.
[17] Liu QH, Paroo Z. Biochemical principles of small RNA pathways. Annu Rev Biochem, 2010, 79(1): 295-319.
[18] Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nat Rev Genet, 2009, 10(2): 94-108.
[19] Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol, 2007, 23(1): 175-205.
[20] Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell, 2009, 136(4): 642-655.
[21] Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saïb A, Voinnet O. A cellular microRNA mediates antiviral defense in human cells. Science, 2005, 308(5721): 557-600.
[22] Li WX, Li HW, Lu R, Li F, Dus M, Atkinson P, Brydon EWA, Johnson KL, García-Sastre A, Ball LA, Palese P, Ding SW. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proc Natl Acad Sci USA, 2004, 101(5): 1350-1355.
[23] Carthew RW. Gene silencing by double-stranded RNA. Curr Opin Cell Biol, 2001, 13(2): 244-248.
[24] Ryther RCC, Flynt AS, Phillips JA III, Patton JG. siRNA therapeutics: big potential from small RNAs. Gene Ther, 2005, 12(1): 5-11.
[25] Ma Y, Chan CY, He ML. RNA interference and antiviral therapy. World J Gastroentero, 2007, 13(39): 5169-5179.
[26] Zamore PD, Tusch

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

抗流感病毒小RNAs研究进展

Research progress on influenza antiviral small RNAs

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	韩玉婷, 许博文, 李羽童, 卢心怡, 董习之, 邱雨浩, 车沁耘, 朱芮葆, 郑丽, 李孝宸, 司绪, 倪建泉. 模式动物果蝇的基因调控前沿技术[J]. 遗传, 2022, 44(1): 3-14.
[2]	周学, 杜宜兰, 金萍, 马飞. 癌症相关microRNA与靶基因的生物信息学分析[J]. 遗传, 2015, 37(9): 855-864.
[3]	付绍印, 赵宏丽, 郑竹清, 李金泉, 张文广. 褪黑激素对绒山羊皮肤中毛囊周期相关miRNAs表达模式的影响[J]. 遗传, 2014, 36(12): 1235-1242.
[4]	樊春燕, 魏强, 郝志强, 李广林. miRNAs调控lincRNAs的生物信息学预测与功能分析[J]. 遗传, 2014, 36(12): 1226-1234.
[5]	龚文芳，路立京，刘鑫，陈喜文，陈德富. 沉默lycB基因对雨生红球藻类胡萝卜素合成代谢的影响[J]. 遗传, 2013, 35(2): 233-240.
[6]	汤海明，陈红，张静，任景怡，许宁. 新一代测序技术应用于microRNA检测[J]. 遗传, 2012, 34(6): 784-792.
[7]	王丽，那威，王宇祥，王彦博，王宁，王启贵，李玉茂，李辉. 鸡PPARγ基因的表达特性及其对脂肪细胞增殖分化的影响[J]. 遗传, 2012, 34(4): 454-464.
[8]	刘伍限，贾斌，石国庆，任建功，刘卡，马润林. 绵羊FGF5基因的克隆、表达及RNA干扰[J]. 遗传, 2011, 33(9): 982-988.
[9]	张磊，晁江涛，崔萌萌，陈雅琼，宗鹏，孙玉合. 茄子microRNAs与其靶基因的生物信息学预测[J]. 遗传, 2011, 33(7): 776-784.
[10]	代蓉，沈思军，万鹏程，石国庆，孟庆勇，刘守仁. Pol Ⅱ型启动子K14实现组织特异RNAi[J]. 遗传, 2011, 33(7): 757-762.
[11]	罗庆苗，苗向阳，张瑞杰. 转基因动物新技术研究进展[J]. 遗传, 2011, 33(5): 449-458.
[12]	董长征. 流感病毒基因组进化研究进展[J]. 遗传, 2011, 33(3): 189-197.
[13]	孟雅楠，孟丽军，宋亚娟，刘美玲，张秀军. 小RNA分子与精子发生调控[J]. 遗传, 2011, 33(1): 9-16.
[14]	冯碧薇，陈建强，雷秉坤，潘贤，吕红. 酵母模式生物研究表观遗传调控基因组稳定性的进展[J]. 遗传, 2010, 32(8): 799-807.
[15]	傅天韵，娄维义，石铁流. 不同宿主H1N1病毒血凝素蛋白(HA)受体结合位点的变异特征[J]. 遗传, 2010, 32(7): 701-711.